Australia markets close in 29 minutes

Xtacy Therapeutics Corp. (TT5.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0190+0.0015 (+8.57%)
At close: 08:14AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-434.781
-519.936
-1,369
-3,584
-1,375
-
Stock-based compensation
-
-
0
3,029
319.502
1,380
Change in working capital
1,041
863.413
652.991
500.395
85.529
-
Accounts receivable
-
-
-
-
-19.47
140.307
Accounts payable
-
-
950.821
500.395
-
-
Other working capital
-76.097
-80.697
-426.295
-98.446
-61.457
-
Other non-cash items
-659.136
-400.882
300.867
254.625
60.64
-
Net cash provided by operating activities
-76.097
-80.697
-426.295
-98.446
-61.457
-
Cash flows from investing activities
Net cash used for investing activities
-
-
-
0
47.176
0
Cash flows from financing activities
Debt repayment
-
0
-78.829
0
-
-
Common stock issued
-
0
407.45
0
0
-
Other financing activities
-701.433
51.675
-
45.05
-
-701.433
Net cash used provided by (used for) financing activities
76.097
80.697
400.667
120.075
0
-
Net change in cash
0
0
-25.628
21.629
-14.281
-
Cash at beginning of period
0
0
25.628
3.999
18.28
-
Cash at end of period
-
0
0
25.628
3.999
-
Free cash flow
Operating cash flow
-76.097
-80.697
-426.295
-98.446
-61.457
-
Free cash flow
-76.097
-80.697
-426.295
-98.446
-61.457
-